CA 19.9 y fibrosis pulmonar / CA 19.9 and pulmonary fibrosis

No disponible

Paciente con poliartritis séptica y osteomielitis multifocal por diseminación hematógena de Estafilococo aureus / Male with septic polyarthritis and multifocal osteomyelitis due to hematogenous dissemination of Estafilococo aureus

No disponible

[Severe isolated pulmonary hypertension as main manifestation of Crest syndrome]. / Hipertensión pulmonar aislada severa como manifestación principal del síndrome Crest.

Interstitial pulmonary fibrosis is the leading cause of secondary pulmonary hypertension in systemic sclerosis, and it occurs in either limited or diffuse cutaneous scleroderma subset. Isolated pulmonary hypertension, without pulmonary disease, occurs primarily in patients with limited cutaneous scleroderma (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasia [CREST] variant) although it is an unusual feature in this subset, with a worse prognosis in the short term. We present a previously undiagnosed patient with the CREST syndrome, with severe isolated pulmonary hypertension and secondary respiratory failure as major feature of its connective tissue disease. Clinical, prognostic and therapeutical aspects are commented.

Hipertensión pulmonar aislada severa como manifestación principal del síndrome Crest / Severe isolated pulmonary hypertension as major feature of the crest syndrome

La fibrosis pulmonar intersticial es la causa más frecuente de hipertensión pulmonar secundaria en la esclerosis sistémica, tanto en el subgrupo de escleroderma cutánea difusa como en el de escleroderma cutánea limitada. La hipertensión pulmonar aislada, no asociada a enfermedad pulmonar, aunque ocurre primariamente en pacientes con escleroderma cutánea limitada y su variante el síndrome CREST (calcinosis, fenómeno de Raynaud, dismotilidad esofágica, esclerodactilia y telangiectasias) constituye un hallazgo infrecuente en este subgrupo, implicando un mal pronóstico a corto plazo. Comunicamos el caso de una paciente con síndrome CREST, no diagnosticada previamente, con hipertensión pulmonar aislada severa e insuficiencia respiratoria secundaria como manifestación principal de su conectivopatía. Se comentan aspectos relacionados con la clínica, pronóstico y manejo terapéutico de estos pacientes (AU)

Esophageal candidiasis in HIV-negative patients.

UNLABELLED: Candida esophagitis is the most frequent esophageal infection in HIV seropositive as well as in seronegative patients. AIM: this retrospective study was designed to determine the characteristics of this disease in HIV negative patients in a general hospital. DESIGN: clinical records of all HIV negative patients with Candida esophagitis, which was endoscopically diagnosed and microscopically confirmed (biopsy and/or cytology of esophageal mucosa), were studied. RESULTS: thirty-one patients (23 men, 8 women, mean age: 65.4 +/- 14.3 years, median 71) fulfilled the criteria (0.56% of the diagnostic esophagogastroduodenal endoscopies). The most common clinical symptoms were dysphagia with or without odynophagia and pain (retrosternal, epigastric or xiphoid). Fourteen patients (45%) had no esophageal signs; in nine of them (29%) the disease was diagnosed in the course of an endoscopic exam to investigate the sources of acute or chronic anaemia. The most frequent predisposing factors were diabetes mellitus, oral or aerosolized corticotherapy, malignancies, treatment with broad-spectrum antibiotics and liver cirrhosis. Nine patients (29%) presented no known predisposing factors. The most common endoscopic appearance was grade II (51%). Sixty-one per cent of the patients exhibited at least one other esophagogastroduodenal endoscopic lesion associated with the mycosis. Three patients died of their underlying diseases within one week of the diagnosis of the candidiasis. Only one patient presented persistence of candidiasis one week after initiating treatment with oral nystatine. CONCLUSIONS: esophageal candidiasis is infrequent and does not always present with suspicious symptoms or known predisposing factors. Aerosolized corticotherapy may be a risk factor for the development of esophageal candidiasis.